AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10813541
Drug: 7 L
RxNorm normalized name: WT-1 427 long
DrugBank: WT-1 427 long (DB17354)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 L leukapheresis
Trial: 10813541
Drug: 10 L
RxNorm normalized name: PEG-10 LANOLIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 L leukapheresis
Trial: 8856576
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids (L-alanine, L-glutamine, L-phenylalanine, L-proline)
Trial: 1478771
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment for 36 weeks followed by active treatment for 30 weeks (crossover group)
Trial: 6139346
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zetidoline
Trial: 29332068
Drug: Oral steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroids (1 mg/kg/day of prednisolone for 6 days prior to surgery)
Trial: 3265156
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no steroids)
Trial: 21719866
Drug: HQ system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HQ system (cleanser, toner, proprietary 4% hydroquinone, exfoliant, and sunscreen) plus 0.05% tretinoin cream
Trial: 10463317
Drug: Naltrexone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 25 mg
Trial: 2167107
Drug: Naltrexone 0
RxNorm normalized name: MORPHINE 20MG/NALTREXONE 0.8MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 0 mg (placebo)
Trial: 11862370
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg
Trial: 11557167
Drug: Naltrexone 100
RxNorm normalized name: naltrexone 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 100 mg
Trial: 7021070
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg flurbiprofen daily
Trial: 7021070
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between flurbiprofen and enteric-coated aspirin
Trial: 7021070
Drug: Side effects
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Side effects reported for aspirin
Trial: 31563881
Drug: Dexamethasone 4
RxNorm normalized name: dexamethasone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 4 mg/mL
Trial: 26413530
Drug: ICP-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICP-guided therapy (ICP < 20 mmHg and CPP > 60 mmHg)
Trial: 15097262
Drug: Dorzolamide/Timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide/Timolol fixed combination
Trial: 9270086
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg felodipine daily for 3 months
Trial: 9270086
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg felodipine daily for 3 months
Trial: 9270086
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg felodipine
Trial: 8665996
Drug: Felodipine treatment
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine treatment
Trial: 7910871
Drug: drugs and
RxNorm normalized name: Prostaglandin analogues, antiglaucoma drugs and miotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: drugs and acupuncture
Trial: 26170126
Drug: Aveeno® lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aveeno® lotion
Trial: 26170126
Drug: Diprobase® cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diprobase® cream
Trial: 26170126
Drug: Doublebase® gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doublebase® gel
Trial: 16801838
Drug: Generic prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generic prednisolone (15 mg/5 ml)
Trial: 16801838
Drug: Orapred (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orapred (15 mg/5 ml)
Trial: 12970289
Drug: Oral calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcitriol and calcium
Trial: 10656170
Drug: gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil (600 mg bid)
Trial: 8683863
Drug: Interleukin-3 (IL-3)
RxNorm normalized name: interleukin-3
DrugBank: Muplestim (DB12431)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-3 (IL-3) therapy with co-administration of granulocyte colony-stimulating factor (G-CSF) and/or erythropoietin (Epo)
Trial: 8683863
Drug: Interleukin-3 (IL-3)
RxNorm normalized name: interleukin-3
DrugBank: Muplestim (DB12431)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-3 (IL-3) therapy with sequential administration of G-CSF and Epo two weeks after IL-3
Trial: 8683863
Drug: Interleukin-3 (IL-3)
RxNorm normalized name: interleukin-3
DrugBank: Muplestim (DB12431)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-3 (IL-3) therapy
Trial: 1861931
Drug: Albuterol syrup
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol syrup (2 mg)
Trial: 1861931
Drug: Metaproterenol syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metaproterenol syrup (10 mg)
Trial: 6409599
Drug: Cinromide (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinromide (1,200 to 4,800 mg/day)
Trial: 27123570
Drug: BCG vaccination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccination 0.05 ml intradermally in the upper left arm within seven days of birth
Trial: 24725468
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (no incentive)
Trial: 18523846
Drug: Ultrasound-guided corticosteroid
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided corticosteroid injection (A1)
Trial: 18523846
Drug: Ultrasound-guided extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided extracorporeal shock wave therapy (A2)
Trial: 18523846
Drug: Ultrasound-guided corticosteroid
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided corticosteroid injection (B1)
Trial: 18523846
Drug: Ultrasound-guided extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided extracorporeal shock wave therapy (B2)
Trial: 15867200
Drug: FU/LV/bevacizumab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FU/LV/bevacizumab (5 mg/kg once every 2 weeks)
Trial: 30451307
Drug: Abatacept treatment
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Abatacept treatment for 6 months
Trial: 11838000
Drug: 1.5 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/d n-3 fatty acids
Trial: 9543078
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (200 microg/daily)
Trial: 3289830
Drug: naproxen CR
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen CR 1000 mg
Trial: 4557308
Drug: Carbenoxolone sodium
RxNorm normalized name: carbenoxolone sodium
DrugBank: Carbenoxolone (DB02329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone sodium 300 mg daily
Trial: 25129247
Drug: Dexketoprofen trometamol
RxNorm normalized name: Dexketoprofen trometamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen trometamol (DT) 12.5 mg
Trial: 14749544
Drug: Bioequivalence assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioequivalence assessment of prednisone formulations
Trial: 11413083
Drug: Nitroglycerin (NTG)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NTG) - 4-hour intravenous infusion
Trial: 3518528
Drug: Enprofylline (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprofylline (1.0 mg/kg)
Trial: 3518528
Drug: Theophylline (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (3.0 mg/kg)
Trial: 31952923
Drug: rVSVN4CT1-EBOVGP1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rVSVN4CT1-EBOVGP1 vaccine (high-dose cohort)
Trial: 29951651
Drug: NC containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NC containing red yeast rice, policosanols, resveratrol and chromium picolinate (10 mg of monacolin K)
Trial: 24831577
Drug: High-dose rosuvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rosuvastatin (40 mg before treatment plus maintenance for 7 days)
Trial: 24831577
Drug: Low-dose rosuvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rosuvastatin (placebo before treatment plus 10 mg maintenance for 7 days)
Trial: 30552406
Drug: Low-dose rosuvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rosuvastatin
Trial: 16118813
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to prescribed antiretroviral therapy
Trial: 10395118
Drug: Limited Sampling
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Limited Sampling Model (LSM) for Drug A
Trial: 10395118
Drug: Limited Sampling
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Limited Sampling Model (LSM) for Drug B
Trial: 26785220
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg GSK2586184 twice daily
Trial: 26785220
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg GSK2586184 twice daily
Trial: 26785220
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg GSK2586184 twice daily
Trial: 15525879
Drug: Alendronate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (5 mg/day)
Trial: 17323185
Drug: Risedronate (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (2.5 mg/day)
Trial: 7959995
Drug: Diuretic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic therapy (Group III)
Trial: 7959995
Drug: No diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No diuretic therapy (Group II)
Trial: 2884723
Drug: Salazosulfapyridine (SI)
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salazosulfapyridine (SI) at a dose of 2 g/day
Trial: 28198205
Drug: 13 mg
RxNorm normalized name: hemin 313 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13 mg / day total MCs
Trial: 28198205
Drug: 27 mg
RxNorm normalized name: aspirin 227 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27 mg / day total MCs
Trial: 26268815
Drug: secukinumab 10
RxNorm normalized name: Secukinumab
DrugBank: Secukinumab (DB09029)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: secukinumab 10 mg/kg i.v. every 2 weeks until week 10
Trial: 19808841
Drug: Strength-based skills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength-based skills training program for dementia caregiving dyads; specific details on dosage and duration not available.
Trial: 10643835
Drug: Estrogen Replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen Replacement Therapy (ERT)
Trial: 11044542
Drug: Alendronate Therapy
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate Therapy
Trial: 1616967
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg twice daily for 7 days)
Trial: 1889980
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or other antimigraine drugs
Trial: 6647211
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose salbutamol given by domestic nebulizers
Trial: 12217456
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Fluoxetine and CBT)
Trial: 2159838
Drug: PCV chemotherapy
RxNorm normalized name: PCV
DrugBank: Penciclovir (DB00299)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PCV chemotherapy (cisplatin 100 mg/m2, cyclophosphamide 600 mg/m2, vindesine 3 mg/m2)
Trial: 453063
Drug: High-fiber diet
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber diet (18.0 g crude fiber)
Trial: 453063
Drug: Low-fiber diet
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fiber diet (1.0 g crude fiber)
Trial: 22718223
Drug: Baseline fasting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline fasting glucose level of 6.1 mmol/L or more
Trial: 22115000
Drug: Methylphenidate transdermal
RxNorm normalized name: methylphenidate Transdermal System
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate transdermal system patch wear times (9, 10, 11, and 12 hours per day)
Trial: 26759138
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose aspirin (81 mg/day) plus folic acid (400 mcg/day)
Trial: 26759138
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus folic acid (400 mcg/day)
Trial: 14748874
Drug: Continuous somatostatin
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous somatostatin infusion for 12 hours starting 30 minutes before ERCP
Trial: 14748874
Drug: Bolus intravenous
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus intravenous injection of somatostatin at the time of cannulation
Trial: 14748874
Drug: Somatostatin groups
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin groups (both continuous infusion and bolus)
Trial: 2713259
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel (Retin A)
Trial: 1100302
Drug: Dexamethasone phosphate
RxNorm normalized name: Dexamethasone Phosphate
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone phosphate (DP) intravenous administration at dosages ranging from 0.05 to 2.0 mg/kg
Trial: 1100302
Drug: 4 mg/ml
RxNorm normalized name: valine 4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/ml parenteral solution of DP
Trial: 1100302
Drug: Experimental high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental high potency preparation of 24 mg/ml
Trial: 24522306
Drug: Oral polio
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polio vaccine (OPV)
Trial: 22122960
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of beta-carotene, vitamins C and E, and magnesium
Trial: 389419
Drug: Glucose-insulin-potassium (GIK)
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-insulin-potassium (GIK) infusion
Trial: 10209349
Drug: Sumatriptan nasal
RxNorm normalized name: SUMAtriptan nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan nasal spray 20 mg
Trial: 10209349
Drug: Sumatriptan nasal
RxNorm normalized name: SUMAtriptan nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan nasal spray 10 mg
Trial: 9673807
Drug: Sumatriptan nasal
RxNorm normalized name: SUMAtriptan nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan nasal spray (both dosages)
Trial: 7633535
Drug: High-cost antibiotics
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-cost antibiotics (amoxicillin plus clavulanate potassium, cefaclor, or cefixime) for persistent middle ear effusions
Trial: 7633535
Drug: Oral decongestants
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral decongestants (alone or in combination with other therapy) at the 6-week visit
Trial: 2755214
Drug: Potassium alone
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium alone (2 g potassium chloride daily)
Trial: 2755214
Drug: Potassium and
RxNorm normalized name: Potassium and/or potassium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium and magnesium combined supplementation (2 g potassium and 1 g magnesium daily)
Trial: 29231588
Drug: Acupoint catgut
RxNorm normalized name: CATGUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint catgut embedding therapy applied at bilateral Tianshu (ST 25), Changqiang (GV 1), bilateral Chengshan (BL 57) and Tigangxue (Extra), once a week for 4 weeks.
Trial: 29231588
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication with 0.2% nitroglycerin ointment, applied externally on the wound, twice daily for 4 weeks.
Trial: 21515290
Drug: Metoprolol monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol monotherapy
Trial: 21515290
Drug: Combined metoprolol
RxNorm normalized name: metoprolol and thiazides, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined metoprolol and felodipin therapy
Trial: 9093709
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus adjuvant chemotherapy
Trial: 17987285
Drug: Voriconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole (400 mg twice on the first day and 200 mg twice on the second day)
Trial: 17112806
Drug: Terbinafine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (250 mg once daily for 3 days)
Trial: 17112806
Drug: Control (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (20 microg/kg intravenous alfentanil without pretreatment)
Trial: 15253849
Drug: Real qi
RxNorm normalized name: San Qi Root
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real qi therapy
Trial: 3307093
Drug: Human chorionic
RxNorm normalized name: human chorionic gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human chorionic gonadotropins (HCG, 5,000 IU I.M. twice per week)
Trial: 30572894
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g krill oil powder
Trial: 25124503
Drug: Parental involvement
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parental involvement in children's anxiety treatment
Trial: 21905086
Drug: tolterodine 4
RxNorm normalized name: tolterodine 4 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine 4 mg long‐acting (LA)
Trial: 17124621
Drug: escitalopram 20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 20 mg + placebo
Trial: 17092965
Drug: escitalopram 20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 20 mg + ketanserin 50 mg
Trial: 12552952
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of 5-FU for 5 days at a dose of 320 mg/m2 (CIV group, n = 6)
Trial: 12552952
Drug: Bolus intravenous
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus intravenous injection of 5-FU for 5 days at a dose of 320 mg/m2 (bolus group, n = 8)
Trial: 2576666
Drug: Carvedilol 50
RxNorm normalized name: carvedilol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 50 mg once daily
Trial: 17851827
Drug: Amine fluoride
RxNorm normalized name: triethylene amine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amine fluoride gel (4000 ppm F)
Trial: 16208800
Drug: PC 7000
RxNorm normalized name: POLYETHYLENE GLYCOL 7000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC 7000 toothbrush (Oral‐B ProfessionalCare 7000)
Trial: 10695793
Drug: Tinidazole 50
RxNorm normalized name: tinidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole 50 mg/kg single dose
Trial: 8670601
Drug: Sulphasalazine (SSZ)
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulphasalazine (SSZ) 2.0 g/day
Trial: 1662583
Drug: Nebulizer with
RxNorm normalized name: AeroNeb Go Nebulizer with Cable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer with 99mTc‐labelled colloidal human serum albumin (0.05 mg, 37 MBq)